ACTRN12622001450707
Recruiting
未知
Investigating the use of biomarkers to predict pregnancy and long term cardiovascular complications in women who develop elevated blood pressure, gestational diabetes, fetal growth restriction or spontaneous preterm labour during pregnancy
ational Heart Foundation0 sites600 target enrollmentNovember 14, 2022
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ational Heart Foundation
- Enrollment
- 600
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Pregnant women at any gestation in pregnancy AND
- •2\. Women who develop elevated blood pressure \>130/80 OR
- •3\. Women who have developed pregnancy complications (Gestational diabetes (GDM), Hypertensive disorder of pregnancy (HDP), Fetal growth restriction(FGR) and spontaneous preterm birth(sPTB))
Exclusion Criteria
- •1\. Multiple pregnancy.
- •2\. Pregnancy complicated by major fetal anomaly or genetic syndrome.
- •3\. Maternal age less than 18 years,
- •4\. Women incapable of giving valid consent (diminished understanding, non\-English speaking
- •and interpreter unavailable).
- •5\. Participation in a study where there is a pharmaceutical intervention that would likely modify the biomarkers under study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Exploring Predictive and Prognostic Biomarkers in People with Cancer.CancerCancer - Any cancerACTRN12623000853640Monash Health500
Completed
Not Applicable
Study for new biomarker development in the prediction of prognosis of renal function in chronic kidney diseaseChronic kidney diseaseJPRN-UMIN000010140Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences216
Recruiting
Not Applicable
Study for new biomarker development in the prediction of prognosis of renal function in chronic kidney diseaseJPRN-UMIN000014093Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences512
Completed
Not Applicable
Study for new biomarker development in the prediction of renal anemia progression in chronic kidney diseaseJPRN-UMIN000008699Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences90
Completed
Not Applicable
An exploratory study to evaluate biomarkers as predictive and /or prognostic factors of benefit from randomized phase ll study of mFOLFOX6+bevacizumab or mFOLFOX6+cetuximab in liver only metastasis from KRAS wild type colorectal cancerliver only metastasis from KRAS Exon 2 wild type (under protocol 1.0-1.2 edition) and RAS wild type (under protocol 2.0 edition) colorectal cancerJPRN-UMIN000010429EPS Corporation100